CapsoVision (CV) Raw Materials (2024 - 2025)

CapsoVision's (CV) quarterly Raw Materials came in at $1.9 million in Q4 2025, up 21.21% year-on-year from $1.6 million in Q4 2024, and up 13.75% quarter-over-quarter from $1.7 million in Q3 2025.

CapsoVision (CV) Raw Materials (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Raw Materials across 2 years of filings, most recently posting $1.9 million for Q4 2025.

  • Raw Materials for Q4 2025 came in at $1.9 million, up 21.21% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.9 million (up 21.21% YoY), and the FY2025 annual result was $1.9 million, up 21.21% from the prior year.
  • Raw Materials came in at $1.9 million for Q4 2025 at CapsoVision, up from $1.7 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.9 million in Q4 2025 to a low of $1.6 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 CapsoVision 161.82 Mn 151.71 Mn 1.95 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.89 Mn
Sep 30, 2025 1.66 Mn
Jun 30, 2025 1.59 Mn
Dec 31, 2024 1.56 Mn